ZNTL - Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu M.D. MPH Hosted by TD Cowen | Benzinga
Investor call to be held on Friday, November 10th, at 10:00 a.m. ET
Company also to participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 15th, 2023 at 8:30 a.m. GMT
NEW YORK and SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Kimberly Blackwell, M.D., Chief Executive Officer of Zentalis, and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will be joined by gynecologic oncology key opinion leader, Joyce F. Liu, M.D., MPH, for an investor call on Friday, November 10th, at 10:00 a.m. ET hosted by TD Cowen to discuss the azenosertib ovarian cancer clinical updates that were announced earlier this week.
Dr. Blackwell will also participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 15th, 2023 at 8:30 a.m. GMT.
Access to live webcasts of both events, as well as archived ...